imipenem cilastatin
Selected indexed studies
- Imipenem-cilastatin. (Obstet Gynecol Clin North Am, 1992) [PMID:1436925]
- Comparative review of imipenem/cilastatin versus meropenem. (Med Mal Infect, 2020) [PMID:32035719]
- Imipenem/Cilastatin in Embolization: From Antibiotic to Therapeutic Agent. (Cardiovasc Intervent Radiol, 2025) [PMID:41184457]
_Worker-drafted node — pending editorial review._
Connections
imipenem cilastatin is a side effect of
Sources
- Imipenem-cilastatin. (1992) pubmed
- Comparative review of imipenem/cilastatin versus meropenem. (2020) pubmed
- Imipenem/Cilastatin in Embolization: From Antibiotic to Therapeutic Agent. (2025) pubmed
- Imipenem cilastatin sodium-associated thrombocytopenia in an older patient: A case report and literature review. (2022) pubmed
- Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii-calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK). (2023) pubmed
- Clinical Pharmacokinetics and Pharmacodynamics of Imipenem-Cilastatin/Relebactam Combination Therapy. (2020) pubmed
- Imipenem-cilastatin sodium, a broad-spectrum carbapenem antibiotic combination. (1986) pubmed
- Imipenem/cilastatin-associated hiccups. (1992) pubmed
- Imipenem/cilastatin/relebactam: A new carbapenem β-lactamase inhibitor combination. (2021) pubmed
- A phase III, randomized, controlled noninferiority trial to study the efficacy and safety of imipenem/cilastatin/relebactam (IMI/REL) vs piperacillin/tazobactam (PIP/TAZ) in patients with hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP). (2025) pubmed